Iovance Biotherapeutics, Inc.

IOVA

$3.88

Name : Iovance Biotherapeutics, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $1,732,429,312.00

EPSttm : -0.92

Iovance Biotherapeutics, Inc.

$3.88

3.00%

$0.12

IOVA — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

27.48

Margin Of Safety %

Put/Call OI Ratio

0.28

EPS Next Q Diff

0.07

EPS Last/This Y

0.53

EPS This/Next Y

0.25

Price

3.87

Target Price

8.8

Analyst Recom

1.5

Performance Q

-25.38

Upside

-957.0%

Beta

0.7

Ticker: IOVA

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-05-11	IOVA	3.7	0.35	0.07	221196
2026-05-12	IOVA	3.57	0.34	0.14	227094
2026-05-13	IOVA	3.65	0.34	0.12	228934
2026-05-14	IOVA	3.51	0.33	0.57	229535
2026-05-15	IOVA	3.45	0.33	0.04	229611
2026-05-18	IOVA	3.37	0.30	0.23	209213
2026-05-19	IOVA	3.47	0.30	0.11	211274
2026-05-20	IOVA	3.54	0.30	0.04	212397
2026-05-21	IOVA	3.69	0.29	0.04	214461
2026-05-22	IOVA	4.1	0.29	0.14	216736
2026-05-26	IOVA	4.11	0.29	0.24	216255
2026-05-27	IOVA	4.36	0.29	0.09	218929
2026-05-28	IOVA	4.29	0.27	0.06	232364
2026-05-29	IOVA	4.09	0.27	0.09	235611
2026-06-02	IOVA	4.09	0.27	0.04	236406
2026-06-03	IOVA	3.8	0.27	0.22	237382
2026-06-04	IOVA	4.38	0.27	0.07	236843
2026-06-05	IOVA	4.22	0.27	0.38	240323
2026-06-08	IOVA	3.99	0.28	0.56	235143
2026-06-09	IOVA	3.87	0.28	0.07	238610
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-05-11	IOVA	3.71	57.4	-2.9	-0.54
2026-05-12	IOVA	3.57	56.5	48.3	-0.58
2026-05-13	IOVA	3.65	56.5	24.5	-0.58
2026-05-14	IOVA	3.52	56.5	49.2	-0.58
2026-05-15	IOVA	3.45	56.5	40.9	-0.58
2026-05-18	IOVA	3.37	56.5	43.3	-0.58
2026-05-19	IOVA	3.47	56.5	22.7	-0.58
2026-05-20	IOVA	3.53	56.5	27.5	-0.58
2026-05-21	IOVA	3.70	56.5	16.8	-0.58
2026-05-22	IOVA	4.11	56.5	-8.0	-0.58
2026-05-26	IOVA	4.11	59.2	34.7	-0.56
2026-05-27	IOVA	4.36	59.2	10.7	-0.56
2026-05-28	IOVA	4.30	59.2	40.4	-0.56
2026-05-29	IOVA	4.09	59.2	52.3	-0.56
2026-06-01	IOVA	3.94	59.2	48.6	-0.56
2026-06-02	IOVA	4.10	59.2	19.5	-0.56
2026-06-03	IOVA	3.80	59.2	62.0	-0.56
2026-06-04	IOVA	4.37	59.2	-22.4	-0.56
2026-06-05	IOVA	4.22	59.2	48.0	-0.56
2026-06-08	IOVA	4.00	59.2	54.8	-0.56
2026-06-09	IOVA	3.87	59.2	46.6	-0.56
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-05-11	IOVA	0.00	13.71	28.41
2026-05-12	IOVA	0.00	13.71	29.95
2026-05-13	IOVA	0.00	13.71	29.95
2026-05-14	IOVA	0.00	13.71	29.95
2026-05-15	IOVA	0.00	13.71	29.95
2026-05-18	IOVA	0.00	10.50	29.57
2026-05-19	IOVA	0.00	10.50	29.57
2026-05-20	IOVA	0.00	10.50	29.57
2026-05-21	IOVA	0.00	10.50	29.57
2026-05-22	IOVA	0.00	10.50	29.57
2026-05-26	IOVA	0.00	1.89	29.57
2026-05-27	IOVA	0.00	1.89	29.57
2026-05-28	IOVA	0.00	1.89	27.48
2026-05-29	IOVA	0.00	1.89	27.48
2026-06-02	IOVA	0.00	1.24	27.48
2026-06-03	IOVA	0.00	1.24	27.48
2026-06-04	IOVA	0.00	1.24	27.48
2026-06-05	IOVA	0.00	1.24	25.57
2026-06-08	IOVA	0.00	1.25	27.48
2026-06-09	IOVA	0.00	1.25	27.48
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.19

Avg. EPS Est. Current Quarter

-0.13

Avg. EPS Est. Next Quarter

-0.12

Insider Transactions

Institutional Transactions

1.25

Beta

0.7

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

86.2

Max Drawdown 5-Year %

-94

Target Price

8.8

P/E

Forward P/E

PEG

P/S

6.07

P/B

2.36

P/Free Cash Flow

EPS

-0.95

Average EPS Est. Cur. Y

-0.56

EPS Next Y. (Est.)

-0.32

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-123.92

Relative Volume

0.75

Return on Equity vs Sector %

-76.5

Return on Equity vs Industry %

-60.4

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.02

EBIT Estimation

46.6

◆ IOVA Healthcare

$3.88

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

2/20

Pullback

17/25

Volume

9/15

Valuation

10/20

TP/AR

2/10

Options

8/10

RSI

49.8

Range 1M

45.1%

Sup Dist

0.3%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

2/25

Growth

23/30

Estimates

0/20

Inst/Vol

4/15

Options

8/10

EPS Yr

49.6%

EPS NY

43.7%

52W%

55.5%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +126.8% upside

Quality

4/30

Valuation

16/30

Growth

17/25

Stability

7/10

LT Trend

1/5

Upside

+126.8%

Quality

Iovance Biotherapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 975

Iovance Biotherapeutics, Inc., a commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States and internationally. The company offers Amtagvi, an individualized T cell therapy for solid tumor cancer and for the treatment of adult patients with previously treated advanced, or unresectable or metastatic melanomal; and Proleukin, an interleukin-2 product for the treatment of patients with metastatic melanoma and metastatic renal cell carcinoma. It also develops lifileucel for the treatment of melanoma, cervical cancer, non-small cell lung cancer (NSCLC), endometrial cancer, and head and neck squamous cell carcinoma (HNSCC); LN-145-S1 to treat melanoma and HNSCC; LN-145 Gen 3 and core biopsy for the treatment of NSCLC; LN-145 Gen 3 to treat melanoma and HNSCC; IOV-2001 to treat chronic lymphocytic leukemia and small lymphocytic lymphoma; IOV-4001 for the treatment of melanoma and NSCLC; and IOV-3001 for use in the TIL therapy treatment regimen. The company has collaborations and licensing agreements with National Institutes of Health; the National Cancer Institute; Cellectis S.A.; Novartis Pharma AG; and Boehringer Ingelheim Biopharmaceuticals GmbH. The company was formerly known as Lion Biotechnologies, Inc. and changed its name to Iovance Biotherapeutics, Inc. in June 2017. Iovance Biotherapeutics, Inc. was incorporated in 2007 and is headquartered in San Carlos, California.

IOVA

Latest News

—

Caricamento notizie per IOVA…

stock quote shares IOVA – Iovance Biotherapeutics, Inc. Stock Price stock today

news today IOVA – Iovance Biotherapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch IOVA – Iovance Biotherapeutics, Inc. yahoo finance google finance

stock history IOVA – Iovance Biotherapeutics, Inc. invest stock market

stock prices IOVA premarket after hours

ticker IOVA fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: IOVA

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y